Target Name: VPS13C
NCBI ID: G54832
Review Report on VPS13C Target / Biomarker Content of Review Report on VPS13C Target / Biomarker
VPS13C
Other Name(s): bridge-like lipid transfer protein family member 5C | DKFZp686E0570 | Vacuolar protein sorting 13 homolog C, transcript variant 2A | Vacuolar protein sorting 13 homolog C, transcript variant 1A | VPS13C variant 2B | Vacuolar protein sorting-associated protein 13C (isoform 1A) | VP13C_HUMAN | VPS13C variant 2A | BLTP5C | Vacuolar protein sorting-associated protein 13C | PARK23 | VPS13C variant 1B | KIAA1421 | Vacuolar protein sorting 13 homolog C, transcript variant 1B | Intermembrane lipid transfer protein VPS13C (isoform 2B) | VPS13C variant 1A | FLJ21361 | Intermembrane lipid transfer protein VPS13C | Vacuolar protein sorting 13 homolog C, transcript variant 2B | vacuolar protein sorting 13 homolog C | OTTHUMP00000163686 | Intermembrane lipid transfer protein VPS13C (isoform 2A) | Intermembrane lipid transfer protein VPS13C (isoform 1B)

VPS13C: A Potential Drug Target and Biomarker

VPS13C is a gene that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative disorders, and psychiatric conditions. The gene, which encodes a protein known as VPS13C, has been shown to play a role in the development and progression of these diseases.

Recent studies have suggested that VPS13C may be involved in the development of cancer by promoting the growth and survival of cancer cells. In addition, VPS13C has also been linked to the development of neurodegenerative disorders, such as Alzheimer's and Parkinson's diseases, as well as psychiatric conditions, such as depression and anxiety.

Despite these promising findings, much more research is needed to fully understand the role of VPS13C in these diseases and to develop effective treatments. One potential approach to studying VPS13C is to use it as a drug target. By targeting the VPS13C protein with small molecules or other compounds, researchers may be able to disrupt its function and prevent the growth and progression of cancer cells, or alleviate the symptoms of neurodegenerative disorders and psychiatric conditions.

Another approach to studying VPS13C is to use it as a biomarker. By analyzing the levels of VPS13C in tissues or fluids, researchers may be able to monitor the effectiveness of potential treatments and identify biomarkers that can predict the outcomes of these treatments. This approach could be particularly useful in the context of psychiatric conditions, where the diagnosis and treatment of such conditions can be challenging.

In addition to its potential as a drug target and biomarker, VPS13C has also been shown to play a role in the regulation of cell division and the development of neural networks. This suggests that it may be involved in the development of various psychiatric conditions, including depression and anxiety.

Overall, the potential of VPS13C as a drug target and biomarker for various psychiatric and neurological disorders makes it an important area of research. Further studies are needed to fully understand its role in these conditions and to develop effective treatments.

Protein Name: Vacuolar Protein Sorting 13 Homolog C

Functions: Mediates the transfer of lipids between membranes at organelle contact sites (By similarity). Necessary for proper mitochondrial function and maintenance of mitochondrial transmembrane potential (PubMed:26942284). Involved in the regulation of PINK1/PRKN-mediated mitophagy in response to mitochondrial depolarization (PubMed:26942284)

The "VPS13C Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about VPS13C comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

VPS13C-DT | VPS13D | VPS16 | VPS18 | VPS25 | VPS26A | VPS26AP1 | VPS26B | VPS26C | VPS28 | VPS29 | VPS33A | VPS33B | VPS35 | VPS35L | VPS36 | VPS37A | VPS37B | VPS37C | VPS37D | VPS39 | VPS41 | VPS45 | VPS4A | VPS4B | VPS50 | VPS51 | VPS51P8 | VPS52 | VPS53 | VPS54 | VPS72 | VPS8 | VPS9D1 | VPS9D1-AS1 | VRK1 | VRK2 | VRK3 | VRTN | VSIG1 | VSIG10 | VSIG10L | VSIG10L2 | VSIG2 | VSIG4 | VSIG8 | VSIR | VSNL1 | VSTM1 | VSTM2A | VSTM2A-OT1 | VSTM2B | VSTM2B-DT | VSTM2L | VSTM4 | VSTM5 | VSX1 | VSX2 | VTA1 | VTCN1 | VTI1A | VTI1B | VTN | VTRNA1-1 | VTRNA1-2 | VTRNA1-3 | VTRNA2-1 | VTRNA3-1P | VWA1 | VWA2 | VWA3A | VWA3B | VWA5A | VWA5B1 | VWA5B2 | VWA7 | VWA8 | VWC2 | VWC2L | VWCE | VWDE | VWF | VXN | WAC | WAC-AS1 | WAKMAR1 | WAKMAR2 | WAPL | WARS1 | WARS2 | WARS2-AS1 | WAS | WASF1 | WASF2 | WASF3 | WASF4P | WASF5P | WASH complex | WASH2P | WASH3P